Bronze Sponsor

IPM.ai, a subsidiary of Swoop, leverages a robust, patient level data set (~280 MM unique, de-identified patients) and cutting-edge machine learning techniques to facilitate the earlier, accurate diagnosis of rare diseases. Earlier and accurate diagnosis in turn facilitates timely intervention and appropriate treatment for rare disease patients, thus improving outcomes and eliminating the costs associated with the misdiagnosis trajectory.